NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,812.00+₹51.00 (+2.9%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
NSE · BIOCON.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:18 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Biocon Limited’s quoted price sits in the lower half of its reported 52-week range, 21.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Biocon Limited’s forward annual dividend is ₹0.50 per share, paid annual. The forward yield is 0.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Biocon Limited’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of ₹1.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Biocon Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 |
|---|
| May 8, 2025 |
| ₹2.81+102.16% vs estimate |
| ₹44.17B+7.75% vs estimate |
| Q3 2025 | Jan 30, 2025 | ₹0.21-83.59% vs estimate | ₹38.56B-1.35% vs estimate |
|---|
| Q2 2025 | Oct 29, 2024 | -₹0.34-161.59% vs estimate | ₹36.02B-0.92% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,812.00+₹51.00 (+2.9%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹9,811.00+₹147.00 (+1.52%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.35% below the high.
₹832.00+₹1.85 (+0.22%)
Anthem Biosciences Ltd.’s quoted price sits in the upper half of its reported 52-week range, 14.89% below the high.
₹1,568.50-₹1.10 (-0.07%)
Onesource Specialty Pharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.23% below the high.
₹406.35+₹7.75 (+1.94%)
Syngene International Limited’s quoted price sits in the lower half of its reported 52-week range, 40.15% below the high.
₹1,258.40+₹27.80 (+2.26%)
Concord Biotech Limited’s quoted price sits in the lower half of its reported 52-week range, 22.08% below the high.
₹147.10-₹2.32 (-1.55%)
Dishman Carbogen Amcis Limited’s quoted price sits in the lower half of its reported 52-week range, 51.45% below the high.
₹426.70-₹13.05 (-2.97%)
Fermenta Biotech Ltd.’s quoted price sits in the upper half of its reported 52-week range, 26.8% below the high.
